Indoor Harvest Corp INQD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.42 Mil
- Volume/Avg
- 8.8 Mil / 13.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Indoor Harvest Corp develops, process, and provide cannabis medicines. The company provides cannabis industry production platforms for building integrated agriculture (BIA) production. It focuses on Genetics, Tissue Culture, Controlled Environment Ag technologies, including high-pressure Aeroponic Cultivation, Micropropagation, and Cultivation operations. It focuses on an integrated consolidation platform offering for cannabis industry companies focused on hemp, other hemp-related products, CBD, CPG, and ancillary business verticals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- https://www.indoorharvest.com
Valuation
|
Metric
|
INQD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
INQD
Financial Strength
|
Metric
|
INQD
|
|---|---|
Quick Ratio | 0.06 |
Current Ratio | 0.06 |
Interest Coverage | −3.98 |
Quick Ratio
INQD
Profitability
|
Metric
|
INQD
|
|---|---|
Return on Assets (Normalized) | −308.39% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −576.49% |
Return on Assets
INQD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qvtmzczvg | Vcz | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Nsxcffvsn | Fvmlsv | $70.8 Bil | |
HLN
| Haleon PLC ADR | Qmqkdvwmp | Rln | $38.2 Bil | |
VTRS
| Viatris Inc | Jpbrlrtd | Klk | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tcjtdrg | Vscw | $12.5 Bil | |
CTLT
| Catalent Inc | Bmnjwbrz | Pqrnnhx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Zhgsnzk | Xhbl | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Hscylcfj | Sfvz | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jtrzgwl | Fdztsx | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Ycwvsyrp | Gdj | $2.9 Bil |